Chinese Biotechnology Industry

China has become the world’s second-largest source of new drugs, running nearly a third of global clinical trials and accounting for almost all licensing in some categories like antibody-drug conjugates.

관련 기사

• 2026-06-20 Don’t restrict Chinese biotech